OPRM1 and Respiratory insufficiency due to muscle weakness: Extending the liability studies, [Nal(2′)4]CJ-15,208 notably also did not produce respiratory depression or the hyperlocomotion associated with morphine and other MOR agonists; indeed, the peptide briefly significantly increased respiration.